Multidrug- and Carbapenem-ResistantPseudomonas aeruginosain Children, United States, 1999–2012 | Zendy

Latania K. Logan | Zendy; Sumanth Gandra | Zendy; Siddhartha Mandal | Zendy; Eili Klein | Zendy; Jordan Levinson | Zendy; Robert A. Weinstein | Zendy; Ramanan Laxminarayan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Multidrug- and Carbapenem-ResistantPseudomonas aeruginosain Children, United States, 1999–2012

Author(s) -

Latania K. Logan,

Sumanth Gandra,

Siddhartha Mandal,

Eili Klein,

Jordan Levinson,

Robert A. Weinstein,

Ramanan Laxminarayan

Publication year - 2016

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piw064

Subject(s) - pseudomonas aeruginosa , medicine , antimicrobial stewardship , odds ratio , carbapenem , multiple drug resistance , antimicrobial , cephalosporin , antibiotics , epidemiology , cystic fibrosis , piperacillin , microbiology and biotechnology , antibiotic resistance , biology , bacteria , genetics

Pseudomonas aeruginosa is a common cause of healthcare-associated infection. Multidrug-resistant (MDR) (>3 classes) and carbapenem-resistant (CR) P aeruginosa are significant threats globally. We used a large reference-laboratory database to study the epidemiology of P aeruginosa in children in the United States.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research